China’s New Pharma Corruption Push Set For At Least A Year

Industry Group Issues New Guidance

As Beijing gets tougher in an all-out campaign to root out corruption and non-compliance in the pharma sector, more physician conferences are jeopardized and an increasing number of hospital presidents are placed under investigation. Meanwhile, one industry association issues new guidance for members. 

Money and handcuffs
China anti-corruption campaign gets tougher on pharma non-compliance • Source: Shutterstock

Many may have seen it coming, but the scale and depth of a renewed anti-corruption campaign in China are still shocking and the pharma/health sector is firmly in authorities' sights.

An enforcement team led by the Communist Party's Disciplinary Committee, along with the National Health Commission (NHC), is leading the charge

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from China

More from Focus On Asia